NIFTY  8,349.35  -1.02%
  SENSEX  27,034.50  -1.00%
 CURRENCY  Rs  68.13/$ 72.75/€, 84.17/£
  GOLD  28,626.00  0.34%
  SILVER  41,395.00  0.30%
  DAX  11,630.10  0.29%
  FTSE  7,198.44  -0.14%
  CAC  4,850.67  0.17%
  HANG SENG  22,885.90  -0.71%
  NIKKEI  19,137.90  0.34%
  Shanghai Composite  3,123.14  0.39%
  DOW JONES  19,827.20  0.48%
  NASDAQ  5,555.33  0.28%
  S&P 500  2,271.31  0.34%
SBI - Approves Allotment Of Shares Worth Rs 5,681 Cr To GOI RUPEE AT CLOSE - Rupee Falls For Sixth Consecutive Week

Sun Pharma-Ranbaxy $4 Bn All-Stock Deal

Video:

Play this video

April 7: Ranbaxy stock has been under severe stress today after Sun Pharma agreed to buy the company in a $4 billion all-stock deal. Ranbaxy investors will get 0.8 share in Sun Pharma for every one of their shares. The deal makes Sun the largest pharma company in India and gives it control over Ranbaxy's pipeline of generic products. Speaking to Bloomberg TV India the management also stressed that they see huge value for Ranbaxy shareholder.